The findings, published in the New England Journal of Medicine, will likely provide further reassurance that the shot is effective against the variant among younger people as the US drug watchdog considers authorising use of the vaccine on children as young as five.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more